Phase III trial of fipamezole in patients with Parkinson's disease.
Phase of Trial: Phase III
Latest Information Update: 03 Sep 2010
At a glance
- Drugs Fipamezole (Primary)
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- 03 Sep 2010 This trial is expected to be initiated in 2011, according to a Santhera media release.
- 03 Sep 2010 New trial record